GSK Sales Reps Speaking Out Against Rx Importation In Grassroots Effort
Executive Summary
GlaxoSmithKline is using its pharmaceutical sales force to advance the company's agenda against drug importation in an attempt to curb growing support for a U.S.-sanctioned policy
You may also be interested in...
Rx Industry Image Fix Will Take More Than Ads, CEOs Say; Is Unity A Risk?
Image advertising is not enough to help rebuild the pharmaceutical industry's public image, AstraZeneca CEO Tom McKillop declared during the Pharmaceutical Leadership Forum Nov. 16 in Washington, D.C
Rx Industry Image Fix Will Take More Than Ads, CEOs Say; Is Unity A Risk?
Image advertising is not enough to help rebuild the pharmaceutical industry's public image, AstraZeneca CEO Tom McKillop declared during the Pharmaceutical Leadership Forum Nov. 16 in Washington, D.C
FDA Will Create “Limited” Rx Import System, Ex-CMS Head Predicts
The Bush Administration will initiate a "limited" pharmaceutical importation program during 2004, former Centers for Medicare & Medicaid Services Administrator Tom Scully predicted during the Medco drug trend symposium May 18 in Lake Buena Vista, Fla